$ASEP Aiming to Capture It's Share of the Antibiotic Market After high relative volume last week, shares of ASEP Medical Holdings $ASEP/$ASEP.C are continuing on a bounce from recent lows after its IPO.
With $ASEP currently working on two products, I’m looking for developments of these products to send shares of $ASEP skyrocketing.
$ASEP’s diagnostic and therapeutic products are focused on addressing current issues in the early diagnosis of sepsis, and the treatment of antibiotic-resistant biofilm infections.
As the global antibiotics market is currently valued at $41.9 billion and is expected to grow at a CAGR of 3%, the subset of sepsis treatments within this market is valued at $1.0 billion and is expected to grow at a much larger CAGR of 8.5%. This represents a massive growth opportunity for $ASEP should it get its products to market. Capturing just a small share of this market would equate to a huge growth opportunity for $ASEP from its current market cap of $36.48 million.
$ASEP is currently trading at $.65 and is valued at an MCAP of $36.48 million. Definitely one to watch this year IMO.
https://asepmedical.com/investors/